SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-030221
Filing Date
2020-10-06
Accepted
2020-10-06 10:42:46
Documents
6
Period of Report
2020-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea127840-8k_silopharma.htm 8-K 22456
2 CERTIFICATE OF AMENDMENT FILED WITH THE DELAWARE SECRETARY OF STATE ON SEPTEMBER ea127840ex3-1_silopharma.htm EX-3.1 534
3 PRESS RELEASE DATED SEPTEMBER 28, 2020 ea127840ex99-1_silopharma.htm EX-99.1 9000
4 PRESS RELEASE DATED OCTOBER 6, 2020 ea127840ex99-2_silopharma.htm EX-99.2 9168
5 GRAPHIC ex99-2_001.jpg GRAPHIC 5247
6 GRAPHIC image_001.jpg GRAPHIC 65489
  Complete submission text file 0001213900-20-030221.txt   140492
Mailing Address 1086 TEANECK ROAD SUITE 3A TEANECK NJ 07666
Business Address 1086 TEANECK ROAD SUITE 3A TEANECK NJ 07666 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 201225858
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl